1. Bioptigen

    0 Comments Leave a Comment

    166-180 of 233 « 1 2 ... 9 10 11 12 13 14 15 16 »
    1. Mentioned In 233 Articles

    2. Bioptigen teams with Brien Holden Vision Institute and Adventus Technology to develop latest innovation for intraoperative OCT

      Bioptigen teams with Brien Holden Vision Institute and Adventus Technology to develop latest innovation for intraoperative OCT
      ...re about Bioptigen’s vision and technology, as well as the company behind it, visit http://www.bioptigen.com. Bioptigen Press Release: The Brien Holden Vision Institute, Adventus Technology, Inc. and Bioptigen Inc., have...
      Read Full Article
    3. Will 2011 be seen as a “Tipping Point” for Industrial Contribution to the Advancement of the Field of Optical Coherence Tomography?

      Comment "See this article http://www.octnews.org/articles/1941968/femto-lasers-in-cataract-surgery/ or this article http://www.aao.org/isrs/resources/outlook/10/04_10_feat.cfm" - Eric Swanson
      Will 2011 be seen as a “Tipping Point” for Industrial Contribution to the Advancement of the Field of Optical Coherence Tomography?
      ...any want-to-bes there are lots of market opportunities!   Eric Swanson OCT News   OCT System Companies: Bioptigen, Cannon Medical Systems/Optopol, Carl Zeiss Meditec, Haag-Streit, Heidelberg Engineering, Heliotis, ...
      Read Full Article
    4. Methods, systems and computer program products for analyzing three dimensional data sets obtained from a sample

      Methods, systems and computer program products for analyzing three dimensional data sets obtained from a sample
      Methods of analyzing three dimensional data sets obtained from a sample over time are provided. A first three dimensional data set is obtained from the sample at a first time. A first volume intensity projection (VIP) image is created from the first three dimensional data set. One or more first landmarks are identified and registered in the first VIP image. A second three dimensional data set is obtained from the ...
      Read Full Article
    5. Direct Scanning of Pathology Specimens Using Spectral Domain Optical Coherence Tomography: A Pilot Study

      Direct Scanning of Pathology Specimens Using Spectral Domain Optical Coherence Tomography: A Pilot Study
      ... Drs. Wollstein, Ishikawa, and Schuman have intellectual property licensed by the University of Pittsburgh to Bioptigen. Dr. Schuman received royalties for intellectual property licensed by Massachusetts Institute of Tec...
      Read Full Article
    6. Optical coherence imaging systems having a mechanism for shifting focus and scanning modality and related adapters

      Optical coherence imaging systems having a mechanism for shifting focus and scanning modality and related adapters
      Some embodiments of the present invention provide adapters for use in posterior imaging systems. The adapters include lens set configured to adapt the posterior imaging system to operate as an anterior imaging system. Related optical coherence tomography systems and anterior imaging systems are also provided herein.
      Read Full Article
    7. Methods, systems and computer program products for removing undesired artifacts in fourier domain optical coherence tomography (fdoct) systems using continuous phase modulation and related phase modulators

      Methods, systems and computer program products for removing undesired artifacts in fourier domain optical coherence tomography (fdoct) systems using continuous phase modulation and related phase modulators
      Methods, fourier domain optical coherence tomography (FDOCT) interferometers and computer program products are provided for removing undesired artifacts in FDOCT systems using continuous phase modulation. A variable phase delay is introduced between a reference arm and a sample arm of an FDOCT interferometer using continuous phase modulation. Two or more spectral interferograms having different phase delay integration times are generated. The spectral interferograms are combined using signal processing to remove ...
      Read Full Article
    8. Methods, Systems And Computer Program Products For Biometric Identification By Tissue Imaging Using Optical Coherence Tomography (Oct) (Wo 2010/062883)

      Methods, Systems And Computer Program Products For Biometric Identification By Tissue Imaging Using Optical Coherence Tomography (Oct) (Wo 2010/062883)
      Optical coherence tomography (OCT) imaging systems for imaging uniquely identifiable structure are provided including a source having an associated source arm path and having an associated reference arm path coupled to the source path, the reference arm path having an associated reference arm path length. A sample having an associated sample arm path coupled to the source arm and reference arm paths is provided. Processing methods to convert the depth-dependent ...
      Read Full Article
    9. 166-180 of 233 « 1 2 ... 9 10 11 12 13 14 15 16 »
  1. Categories

    1. Applications:

      Art, Cardiology, Dentistry, Dermatology, Developmental Biology, Gastroenterology, Gynecology, Microscopy, NDE/NDT, Neurology, Oncology, Ophthalmology, Other Non-Medical, Otolaryngology, Pulmonology, Urology
    2. Business News:

      Acquisition, Clinical Trials, Funding, Other Business News, Partnership, Patents
    3. Technology:

      Broadband Sources, Probes, Tunable Sources
    4. Miscellaneous:

      Jobs & Studentships, Student Theses, Textbooks
  2. About Bioptigen

    Bioptigen

    Bioptigen.  Bioptigen was acquired by Leica Microsystems in 2015.  Ophthalmology and General Research Systems.  Bioptigen has pioneered a new class of in vivo optical imaging systems for biomedical applications. These systems enable real-time non-invasive imaging of internal tissue microstructure, advancing critical applications in drug development, genetics research, tissue engineering, and medical vision.  Bioptigen is a spin-out of the Duke University Biomedical Engineering Department. Bioptigen was incorporated in North Carolina in August, 2004, to commercialize technologies originating in the laboratories of Professor Joseph Izatt. Bioptigen technology is based on the science of Optical Coherence Tomography (OCT), an imaging system similar in function to ultrasound, but using low-power light rather than sound waves. OCT offers resolution 100-times finer than standard ultrasound, suitable for analyzing tissue microstructure with features smaller than 10 micrometer.

  3. Quotes about Bioptigen

    1. Bioptigen allows you to sum up multiple images of a particular cut.
      In New Technology: Bioptigen SDOCT Boosts Flexibility
    2. Bioptigen is very pleased to extend its relationship with Case through this new technology agreement.  The intellectual property licensed by Case is fundamental to our ability to provide the highest performance FDOCT imaging system today and to develop new clinical tools that will dramatically extend the clinical value of FDOCT into the future.
      Eric L. Buckland in Case Western Reserve University, University Hospitals Case Medical Center and Bioptigen Establish Exclusive Licensing Agreement
    3. We look forward to working with Bioptigen to incorporate the Case technology and expand their product portfolio to address medical disciplines beyond ocular imaging.
      In Case Western Reserve University, University Hospitals Case Medical Center and Bioptigen Establish Exclusive Licensing Agreement